January 2022 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2023 Concepts

FY 2023 Small Business Innovation Research (SBIR) Contract Solicitation Topics

Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) To Accelerate Diagnostic and Vaccine Development

For the published request for applications, check the May 13, 2022 Guide announcement, Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) To Accelerate Diagnostic and Vaccine Development (R01, Clinical Trial Not Allowed).

Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease

Request for Applications—proposed FY 2023 initiative

Contact
Sam Perdue
sperdue@niaid.nih.gov

Objective: To encourage research to explore and understand the underlying mechanisms for persistent symptoms attributed to Lyme disease.

Description: The focus of this initiative is to better understand the persistent symptoms that are attributed to Lyme disease. Applications may focus on the following general topics:

  • Pathogenesis of post-treatment sequelae of Lyme disease, including persistent arthritis (post-antibiotic Lyme arthritis) and lingering cognitive symptoms, musculoskeletal pain and fatigue (post-treatment Lyme disease syndrome)
  • Biomarkers and biosignatures to identify those at risk for persistent symptoms and to explore how host inflammatory and autoimmune responses may change over time
  • Studies addressing persistent post-treatment symptoms in Lyme disease compared with those described for other infectious diseases

Partnerships for the Development of Vaccines Against Select Bacterial Enteric Pathogens

For the published request for applications, check the May 10, 2022 Guide announcement, Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01, Clinical Trial Not Allowed).

Partnerships for the Development of Novel Therapeutics To Combat Select Antibiotic-Resistant Bacteria and Fungi

For the published request for applications, check the April 5, 2022 Guide announcement, Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed).

Development and Optimization of Next-Generation Immunological Assays To Support Influenza Clinical Studies and Trials

For the published request for applications, check the April 5, 2022 Guide announcement, Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed).

Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery

For the published notice of special interest, check the December 2, 2021 Guide notice, Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery.

Notice of Special Interest (NOSI)—Advancing Research Needed To Develop a Universal Influenza Vaccine

For the published notice of special interest, check the December 13, 2021 Guide notice, Notice of Special Interest (NOSI)—Advancing Research Needed To Develop a Universal Influenza Vaccine.

Adaptation of CRISPR-Based In Vitro Diagnostics for Rapid Detection of Select Eukaryotic Pathogens

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2023-1.

Request for Proposals

Contact
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Artificial Intelligence To Improve Clinical Microscopy for Diagnosis of Infectious Diseases

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2023-1.

Request for Proposals

Contact
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Modular Sample Preparation for In-Field Viral Discovery

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2023-1.

Request for Proposals

Contact
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Advanced and Immersive Visualization Tools for Infectious and Immune-Mediated Disease Research

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2023-1.

Request for Proposals

Contact
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Data Science Tools for Infectious and Immune-Mediated Disease Research

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2023-1.

Request for Proposals

Contact
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Content last reviewed on